Segantii Capital Management LTD Astrazeneca PLC Transaction History

Segantii Capital Management LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 06, 2021	SELL	$48.42 - $60.18 $7.19 Million - $8.94 Million	-148,583 Closed	0 $0
Q1 2021 May 11, 2021	BUY	$47.16 - $54.44 $7.01 Million - $8.09 Million	148,583 New	148,583 $7.39 Million
Q1 2020 May 08, 2020	SELL	$37.79 - $51.33 $3.08 Million - $4.19 Million	-81,609 Closed	0 $0
Q4 2019 Jan 30, 2020	SELL	$42.46 - $50.46 $233,530 - $277,530	-5,500 Reduced 6.31%	81,609 $4.08 Million
Q3 2019 Oct 24, 2019	BUY	$40.12 - $45.47 $3.49 Million - $3.96 Million	87,109 New	87,109 $3.89 Million

1,334

476M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $218B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Segantii Capital Management LTD, based on Form 13F filings with the SEC.

Stay updated on Segantii Capital Management LTD with notifications on news.